Kohtala, Samuel http://orcid.org/0000-0001-9249-085X
Funding for this research was provided by:
Orionin Tutkimussäätiö
Emil Aaltosen Säätiö
Sigrid Juséliuksen Säätiö
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 11 October 2020
Revised: 3 February 2021
Accepted: 6 February 2021
First Online: 20 February 2021
Compliance with ethical standards
:
: S.K. is listed as a co-inventor on a patent application wherein new tools enabling the development of rapid-acting antidepressants and the efficacy monitors thereof are disclosed based on the basic principles of ENCORE-D. S.K. has assigned his patent rights to the University of Helsinki but will share a percentage of any royalties that may be received by the University of Helsinki.